BioDelivery Sciences International, Inc. (BDSI)
$4.12
-0.04 (-0.96%)
| CAPS Rating |
|
|---|---|
| Open | $0.00 |
| Previous Close | $4.12 |
| Daily Range | $4.05 - $4.26 |
| 52-Week Range | $2.11 - $8.29 |
| Market Cap | $86.66M |
| P/E Ratio | 0.00 |
| Dividend (Yield) | N/A (N/A) |
| Volume | 103,258 |
| Average Daily Volume | 148,000 |
BDSI
VS S&P 500 (SPY)
This ticker is not currently Ratable.
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
BDSI Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
BDSI News and Commentary
- 5-Star Stocks on the Upswing – The Motley Fool
- Tomorrow's Monster Stock? – The Motley Fool
- 4-Star Stocks on the Upswing – The Motley Fool
- Today's 5-Star Movers – The Motley Fool
- Next hidden gem? Bio-Tech stock to closely watch! – Blog at The Motley Fool
- $700M potential drug just Approved by FDA – Blog at The Motley Fool
- Today's 5-Star Movers – The Motley Fool
- 5 Stocks Bucking the Downtrend – The Motley Fool
- 5 Stocks Ready to Bounce Back – The Motley Fool
- BioDelivery Sciences International (BDSI) FDA Decision June 15, 2009 – Blog at The Motley Fool
- Trading the FDA: BioDelivery Sciences Could Have a Big '09 – Blog at The Motley Fool
- Likely Big Movers on Pending FDA Decisions – Blog at The Motley Fool
Related News and Articles
- How Do You Say 'Drug Development' in Mandarin? – The Motley Fool
- 3 Stocks Hitting High Notes – The Motley Fool
- Pharma Researchers Need a Cure – The Motley Fool
- The Waters Aren't Flowing. Yet. – The Motley Fool
- Ugly, but Still Built for Growth – The Motley Fool
- Taking the Drug Industry's Temperature – The Motley Fool
RSS Headlines
Fool UK
